CAMP and cancer: Activation of FPRL-1 by LL-37 has been implicated in immune surveillance against neoplastic transformation, wherein cells of the immune system such as natural killer lymphocytes (NKs) and type 1 CD4+ T lymphocytes recognize and destroy cancer cells (Ostrand-Rosenberg 2008).